文献速递前列腺增生与排尿功能障碍

良性前列腺梗阻的微创治疗:系统评价与网状Meta分析

Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
PubMed 文献 · Eur Urol · 2023-03-22

该系统评价与网状Meta分析检索了63项随机对照试验,比较水蒸气热疗(WVTT)、前列腺尿道悬吊(PUL)、前列腺动脉栓塞(PAE)、临时植入式镍钛装置(iTIND)、经尿道微波热疗(TUMT)与经尿道前列腺电切术(TURP)的疗效、安全性与耐受性。结果显示PAE、PUL、WVTT的症状和生活质量改善与TURP相似,但TURP对尿流率的改善最具临床意义;射精功能比较倾向于WVTT和PUL优于TURP。作者结论认为PAE、PUL和WVTT从风险-获益角度看较为有利,但客观结局的疗效可能低于TURP,这些发现需通过长期随机对照试验确认。

要点

  • PAE、PUL和WVTT的症状与生活质量改善与TURP相似,但TURP对尿流率的改善最具临床意义。
  • TUMT疗效低于TURP,但在生活质量方面提供相似结果。
  • 射精功能比较倾向于WVTT和PUL优于TURP;iTIND的相对疗效因相应试验存在偏倚风险而不够明确。

核心结论

  • 从风险-获益角度看,PAE、PUL和WVTT似乎较为有利,尽管其客观结局的疗效可能低于TURP。
  • 这些发现需通过长期随机对照试验确认。

研究设计与样本

  • 系统检索MEDLINE/PubMed、Embase、Cochrane Library和灰色文献中的随机对照试验,采用Cochrane RoB2工具评估偏倚风险,并使用网状Meta分析比较各治疗。
  • 共纳入63项试验。

主要发现

  • PAE、PUL和WVTT的症状与生活质量改善与TURP相似。
  • TURP对尿流率的改善最具临床意义。
  • TUMT疗效低于TURP,但在生活质量方面提供相似结果。
  • 射精功能比较倾向于WVTT和PUL优于TURP。
  • iTIND的相对疗效因相应试验存在偏倚风险而不够明确。

临床怎么用

  • 作者结论认为PAE、PUL和WVTT从风险-获益角度看较为有利,尽管客观结局的疗效可能低于TURP。
  • 作者结论认为这些发现需通过长期随机对照试验确认。

局限性

  • 这些治疗尚未以随机方式相互比较,且部分治疗没有与参考技术对照的试验。
  • iTIND的相对疗效因相应试验存在偏倚风险而不够明确。
  • 这些发现需通过长期随机对照试验确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Minimally invasive surgical therapies for male lower urinary tract symptoms secondary to benign prostatic obstruction were developed to be safer and more tolerable than standard ablative techniques. These treatments have not been compared with each other in a randomised fashion, and for some treatments, there are no trials against a reference technique. OBJECTIVE: To compare the efficacy, safety, and tolerability of water vapour thermal therapy (WVTT), prostatic urethral lift (PUL), prostatic arterial embolisation (PAE), temporary implantable nitinol device (iTIND), transurethral microwave thermotherapy (TUMT), and transurethral resection of the prostate (TURP). EVIDENCE ACQUISITION: A systematic search of MEDLINE/PubMed, Embase, Cochrane Library, and grey literature for randomised controlled trials was performed. Trials meeting the selection criteria were assessed for the risk of bias using the Cochrane RoB2 tool. Treatments were compared, using a network meta-analysis, in terms of outcomes including symptom score, quality of life, maximum urinary flow rate, postvoid residual urine, International Index of Erectile Function (IIEF-5), and scales from the Male Sexual Health Questionnaire. EVIDENCE SYNTHESIS: The search identified 63 trials. Symptoms and quality of life for PAE, PUL, and WVTT appeared similar to those for TURP, whereas TURP was found to have the most clinically significant improvement in flow rate. TUMT was less efficacious than TURP but provided similar results on quality of life. Comparisons of ejaculatory function favoured WVTT and PUL compared with TURP. The relative efficacy of iTIND was less clear because of the risk of bias in the respective trial. CONCLUSIONS: PAE, PUL, and WVTT appear favourable from a risk-benefit perspective despite probably having less efficacy than TURP for objective outcomes. These findings warrant confirmation through long-term randomised controlled trials. PATIENT SUMMARY: This paper has summarised the evidence from 63 clinical trials on minimally invasive surgical therapies for men with symptoms of an enlarged prostate, including water vapour thermal therapy (WVTT), prostatic urethral lift (PUL), prostatic arterial embolisation (PAE), temporary implantable nitinol device, and transurethral microwave thermotherapy (TUMT). Improvement in symptoms for each of PAE, PUL, TUMT, and WVTT in short-term follow-up was similar to that for the standard surgical treatment, although standard surgery appeared to provide the greatest increase in urine flow. Men who had WVTT or PUL were less likely to have problems with sexual function than those who had standard surgery.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Cornu JN, Zantek P, Burtt G, et al. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis. Eur Urol. 2023. PMID: 36964042. doi:10.1016/j.eururo.2023.02.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。